Urology News and Research

Latest Urology News and Research

Frutarom reports increased demand for natural ingredient targeting urinary incontinence in adults

Frutarom reports increased demand for natural ingredient targeting urinary incontinence in adults

Researchers use data to identify different forms of prostate cancers and effective treatment options

Researchers use data to identify different forms of prostate cancers and effective treatment options

Research shows PODXL protein contributes to aggressive forms of bladder cancer

Research shows PODXL protein contributes to aggressive forms of bladder cancer

Researchers explore targeted therapies for prostate cancer

Researchers explore targeted therapies for prostate cancer

SonaCare Medical highlights need for image-guided technologies to better identify prostate cancer

SonaCare Medical highlights need for image-guided technologies to better identify prostate cancer

UC Irvine chemists create new method to identify clinically usable markers for prostate cancer in urine

UC Irvine chemists create new method to identify clinically usable markers for prostate cancer in urine

Physicians face medical challenges in treating spine trauma in morbidly obese patients

Physicians face medical challenges in treating spine trauma in morbidly obese patients

Mid-stream urine collection system: an interview with Giovanna Forte, Managing Director, Forte Medical

Mid-stream urine collection system: an interview with Giovanna Forte, Managing Director, Forte Medical

Research suggests that IMRT may not be more effective in patients who had prostatectomy

Research suggests that IMRT may not be more effective in patients who had prostatectomy

UCLA study: Older men with multiple underlying health problems should avoid prostate cancer treatment

UCLA study: Older men with multiple underlying health problems should avoid prostate cancer treatment

Long-term success rates of surgery to treat pelvic organ prolapse are lower than expected

Long-term success rates of surgery to treat pelvic organ prolapse are lower than expected

Prostate cancer drug Xofigo gets FDA approval

Prostate cancer drug Xofigo gets FDA approval

More studies needed to determine how decision aids help guide choices for cancer screening

More studies needed to determine how decision aids help guide choices for cancer screening

Uroplasty highlights results of STEP Study on PTNS treatments for overactive bladder

Uroplasty highlights results of STEP Study on PTNS treatments for overactive bladder

Study finds disparity in live-donor kidney transplants in African Americans

Study finds disparity in live-donor kidney transplants in African Americans

Exosome Diagnostics' urine exosome technology accurately predicts outcome of prostate biopsy

Exosome Diagnostics' urine exosome technology accurately predicts outcome of prostate biopsy

UCSF researchers find new genomic test to identify aggressive form of prostate cancer

UCSF researchers find new genomic test to identify aggressive form of prostate cancer

Robotic partial nephrectomy involves excessive hospital charges

Robotic partial nephrectomy involves excessive hospital charges

Study: Patients are more likely to have recurrence of cancer after bladder removal

Study: Patients are more likely to have recurrence of cancer after bladder removal

Taking strong anticholinergic doubles risk of developing cognitive impairment in older adults

Taking strong anticholinergic doubles risk of developing cognitive impairment in older adults

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.